References
References
- Brem , S , Cotran , R and Folkman , J . 1972 . Tumor Angiogenesis: a quantitative method for histologic grading . J Nat. Cancer Inst. , 48 : 347 – 356 .
- Folkman J 1997 Angiogenesis Holland JF Cancer Medicine 4th edn. Williams & Wilkins Baltimore 181
- Epstein JI 2002 Ch. 86 Retik AB Vaughan ED Wein AJ Kavoussi LR Novick AC Partin AW In Pathology of Prostatic Neoplasia, Campbell's Urology 8th edn. Saunders Philadelphia 4 3025 3037
- Jonathan IE Kirk JW 1999 Ch. 45 Sternberg SS Antinioli DA Carter D Mills SE Oberman HA The prostate and seminal vesicles in diagnostic surgical pathology 3rd edn. Lippincott Williams and Wilkins Philadelphia 2 1902
- Catalona , WJ , Bartsch , G , Rittenhouse , HG , Evans , CL , Linton , HJ and Amirkhan , A . 2003 . Serum pro-prostate specific antigen improves cancer detection compared to free and complexed prostate specific antigen in men with prostate specific antigen 2–4 ng/ml . J. Urol. , 170 : 2181 – 2185 .
- Carter HB Partin AW 2002 Ch. 88 Retik AB Vaughan ED Wein AJ Kavoussi LR Novick AC Partin AW In Diagnosis and Staging of Prostate Cancer, Campbell's Urology 8th edn. Saunders Philadelphia 4 3055 3079
- Carter , HB . 2000 . A PSA threshold of 4.0 ng/ml for early detection of prostate cancer: the only rational approach for men 50 years old and older . Urology , 55 : 796
- Jones , A and Fujiyama , C . 1999 . Angiogenesis in urological malignancy: prognostic indicator and therapeutic target . BJU Int. , 83 : 535 – 555 .
- Evegad , L , Granfors , T , Karlberg , L , Bugh , A and Stattin , P . 2002 . Prognostic value of the Gleason score in prostate cancer . BJU Int. , 91 : 538 – 542 .
- Shigeno , K , Igawa , M , Shiina , H , Kishi , H and Urakami , S . 2000 . Transrectal color doppler ultrasonography for quantifying angiogenesis in prostate carcinoma . BJU Int. , 91 : 223 – 336 .
- Rubin , MA , Buyyounouski , M , Bagiella , E , Sharir , S and Neugut , A . 1999 . Microvessel density in prostate cancer: lack of correlation with tumor grade. Pathologic stage, and clinical outcome . Urology , 53 ( 3 ) : 542 – 547 .